Overall rank by patents
#29,406
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06F (Electric Digital Data Processing).
The verdict
According to USPTO PatentsView, MD ranks #29,406 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R29406 · US Corporation #29,406 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Mayne Pharma International PTY. Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
MD Health RX Solutions · this assignee
48 score
3D Lighting… · lowest
7 score
What this shows MD's Innovation Score is 48.1/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
MD Health RX Solutions, LLC is a focused PatentsView assignee: 9 CPC subclasses with 77.8% of grants classified under G06F (Electric Digital Data Processing). Peak complete grant year is 2024 (7 grants) versus a trough of 2 in 2023. By volume, MD sits between Mayne Pharma International PTY. Ltd and Medicines360.
MD Health RX Solutions, LLC shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mayne Pharma International PTY. Ltd
9 patents
MBA B.V.
9 patents
Mclear & Co.
9 patents
Mcor Technologies Limited
9 patents
Medi USA, L.P.
9 patents
Medical Device Engineering, LLC
9 patents
Medical Microinstruments S.P.A.
9 patents
Medicines360
9 patents
MD Health RX Solutions, LLC
9 patents
What this shows MD holds 9 patents at rank #29,361, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,361 in granted patent volume.
Other assignees with the most granted patents in MD's primary technology class.
MD's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 22.2% |
| 2024 | 7 | 77.8% |
Top 9 of 9 technology areas
Overall rank by patents
#29,406
of 49,997 tracked assignees
48.1 out of 100
What to do with this data
MD Health RX Solutions, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.